Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single nucleotide polymorphisms influence methotrexate resistance in low-risk gestational trophoblastic neoplasia
TCTR20180430002Recruiting
- Sponsor
- Ratchadapisek Sompoch Endowment Fund
- Start
- Mar 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methotrexate in trophoblastic tumour, sponsored by Ratchadapisek Sompoch Endowment Fund. Primary endpoint: Association between SNPs and methotrexate resistance. Started Mar 2018; status: recruiting.
02
Drugs
methotrexate
03
Conditions
trophoblastic tumour
Beyond the preview
Go deeper on TCTR20180430002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180430002.